文献速递呼吸衰竭与机械通气心脑血管急症重症综合管理与镇静镇痛

急性症状性肺栓塞患者心率与死亡率的关系

Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism.
PubMed 文献 · Chest · 2021-08-31
一句话结论非低血压急性症状性肺栓塞患者中,入院心率越高,30天全因及肺栓塞相关死亡风险越高;将sPESI心率切点改为80次/分、Bova评分心率切点改为140次/分可改善风险分层。

该研究基于2001—2021年RIETE注册数据库,纳入44,331例连续的非低血压症状性肺栓塞患者,采用分层logistic回归分析入院心率与30天全因死亡及肺栓塞相关死亡的关系。以心率80~99次/分为参照,心率100~109、110~119、120~139、≥140次/分的校正OR分别为1.5、1.7、1.9、2.4;心率60~79、<60次/分的校正OR分别为0.6、0.5。将sPESI的心率切点由110次/分改为80次/分,敏感性由93.4%升至98.8%;将Bova评分心率切点由110次/分改为140次/分,特异性由93.2%升至98.0%。

要点

  • 非低血压症状性肺栓塞患者中,入院心率≥100次/分即与30天全因死亡风险升高相关(校正OR 1.5),且随心率分层升高至≥140次/分时校正OR达2.4。
  • 心率60~79次/分及<60次/分者30天全因死亡风险低于80~99次/分参照组(校正OR分别为0.6、0.5)。
  • 用80次/分替代110次/分作为sPESI心率切点,识别低危患者的敏感性由93.4%提高至98.8%。
  • 用140次/分替代110次/分作为Bova评分心率切点,识别中高危患者的特异性由93.2%提高至98.0%。
  • 30天肺栓塞相关死亡的结果与全因死亡相似。

适用人群与场景

  • 2001—2021年RIETE注册数据库中44,331例连续的非低血压(nonhypotensive)急性症状性肺栓塞患者。

诊断标准与关键阈值

  • 简化肺栓塞严重指数(sPESI)中心率切点由110次/分改为80次/分,用于识别低危患者,敏感性由93.4%升至98.8%。
  • Bova评分中心率切点由110次/分改为140次/分,用于识别中高危患者,特异性由93.2%升至98.0%。
  • 心率分层:<60、60~79、80~99(参照)、100~109、110~119、120~139、≥140次/分。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:基于RIETE注册数据库的回顾性队列分析,纳入44,331例非低血压症状性肺栓塞患者,采用分层logistic回归评估入院心率与30天全因死亡及肺栓塞相关死亡的关系。
  • 以心率80~99次/分为参照,30天全因死亡校正OR:100~109次/分1.5、110~119次/分1.7、120~139次/分1.9、≥140次/分2.4;60~79次/分0.6、<60次/分0.5。
  • 30天肺栓塞相关死亡结果与全因死亡相似。
  • sPESI心率切点由110次/分改为80次/分,识别低危患者敏感性由93.4%升至98.8%;Bova评分心率切点由110次/分改为140次/分,识别中高危患者特异性由93.2%升至98.0%。

证据类型、等级与局限

  • 证据类型:基于注册数据库的回顾性队列研究(观察性研究),非随机对照试验。
  • 局限:原文未明确列出局限;设计本身为观察性、注册数据库回顾性分析,存在混杂可能。

对床旁实践的改变

  • 对非低血压急性症状性肺栓塞患者,入院心率可作为30天死亡风险的分层指标,心率≥100次/分即提示风险升高,≥140次/分风险更高。
  • 应用sPESI识别低危患者时,可考虑将心率切点由110次/分调整为80次/分以提高敏感性(93.4%→98.8%)。
  • 应用Bova评分识别中高危患者时,可考虑将心率切点由110次/分调整为140次/分以提高特异性(93.2%→98.0%)。
  • 原文未提及上述切点调整对治疗决策(如溶栓、收住ICU)的影响,不能据此推断。

指南或共识出处

  • 原文未提及指南或共识名称;研究数据来源于Registro Informatizado de la Enfermedad TromboEmbólica(RIETE)注册数据库。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: The association between heart rate (HR) and pulmonary embolism (PE) outcomes has not been well studied. Furthermore, optimal cutoffs to identify low-risk and intermediate- to high-risk patients are not well known.

RESEARCH QUESTION: Does an association exist between baseline HR and PE outcome across the continuum of HR values?

STUDY DESIGN AND METHODS: The current study included 44,331 consecutive nonhypotensive patients with symptomatic PE from the Registro Informatizado de la Enfermedad TromboEmbólica registry between 2001 and 2021. Outcomes included 30-day all-cause and PE-specific mortality. We used hierarchical logistic regression to assess the association between admission HR and outcomes.

RESULTS: A positive relationship was found between admission HR and 30-day all-cause and PE-related mortality. Considering an HR of 80 to 99 beats/min as a reference, patients in the higher HR strata showed higher rates of all-cause death (adjusted OR, 1.5 for HR of 100-109 beats/min; adjusted OR, 1.7 for HR of 110-119 beats/min; adjusted OR, 1.9 for HR of 120-139 beats/min; and adjusted OR, 2.4 for HR of ≥ 140 beats/min). Patients in the lower strata of HR showed significantly lower rates of 30-day all-cause mortality compared with the same reference group (adjusted OR, 0.6 for HR of 60-79 beats/min; and adjusted OR, 0.5 for HR of < 60 beats/min). The findings for 30-day PE-related mortality were similar. For identification of low-risk patients, a cutoff value of 80 beats/min (vs 110 beats/min) increased the sensitivity of the simplified Pulmonary Embolism Severity Index (sPESI) from 93.4% to 98.8%. For identification of intermediate- to high-risk patients, a cutoff value of 140 beats/min (vs 110 beats/min) increased the specificity of the Bova score from 93.2% to 98.0%.

INTERPRETATION: In nonhypotensive patients with acute symptomatic PE, a high HR portends an increased risk of all-cause and PE-related mortality. Modifying the HR cutoff in the sPESI and the Bova score improves prognostication of patients with PE.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Jaureguízar A, Jiménez D, Bikdeli B, et al. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism. Chest. 2021. PMID: 34478718. doi:10.1016/j.chest.2021.08.059

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。